Drug Interaction Checker

Check for potential drug-drug interactions between your medications. Enter multiple drugs to find known interactions with severity ratings from FDA data.

Khởi động công cụ →

Understanding Drug Interactions

Drug interactions occur when two or more medications affect each other's effectiveness or produce unexpected side effects. Interactions can be pharmacokinetic (affecting absorption, distribution, metabolism, or excretion) or pharmacodynamic (additive, synergistic, or antagonistic effects at the target site).

Severity classifications help prioritize clinical action: major interactions may be life-threatening or require treatment modification; moderate interactions require close monitoring; minor interactions are generally manageable with standard care. The FDA's drug label and clinical trial data are the primary sources for interaction records in our database.

Always consult a pharmacist or physician before combining prescription medications, over-the-counter drugs, or herbal supplements. Drug interaction databases capture documented interactions but cannot predict every possible combination.

Được tham chiếu trong hướng dẫn

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

How to Use

1
Enter your medication list
Type or paste the generic or brand names of all medications you are currently taking, including over-the-counter drugs, vitamins, and herbal supplements. The checker searches FDA drug interaction databases and clinical pharmacology literature.
2
Review flagged interaction pairs
The tool displays each drug pair with a severity rating (major, moderate, or minor) derived from published pharmacokinetic and pharmacodynamic studies. Major interactions indicate contraindicated combinations or those requiring immediate physician review.
3
Consult a pharmacist or prescriber
Use the interaction summaries as a conversation guide when speaking with your healthcare provider. The tool references interaction mechanisms such as CYP450 enzyme inhibition, QT prolongation risk, and additive CNS depression to support informed clinical decisions.

About

Drug interaction checking is a foundational component of medication safety, addressing one of the most preventable causes of adverse drug events. An interaction occurs when one drug alters the pharmacokinetics or pharmacodynamics of another, producing an effect that differs from either agent taken alone. The FDA Adverse Event Reporting System (FAERS) and published pharmacoepidemiology studies consistently identify drug-drug interactions as contributors to hospitalizations, emergency visits, and preventable deaths, particularly in elderly patients managing multiple chronic conditions.

Pharmacological mechanisms underlying interactions include cytochrome P450 enzyme inhibition or induction, P-glycoprotein transport modulation, plasma protein binding displacement, and additive effects on shared physiological targets such as cardiac ion channels, blood pressure, blood glucose, or clotting pathways. The clinical significance of any interaction depends on the drugs' therapeutic index, the patient's organ function, and whether safer alternatives exist. For high-alert medications such as warfarin, digoxin, lithium, and narrow-therapeutic-index immunosuppressants, even moderate interactions warrant close clinical monitoring.

This tool draws on FDA-approved prescribing information, clinical pharmacology monographs, and established interaction databases to provide evidence-based severity ratings for common drug pairs. Users are encouraged to bring flagged interactions to their pharmacist or prescriber, who can assess individual risk factors and determine whether dose adjustment, alternative therapy, or enhanced monitoring is appropriate. Medication reconciliation at every care transition is recognized by the Joint Commission and WHO Patient Safety Challenge as an essential safety practice.

FAQ

What drug interaction severity levels does the checker use?

The checker classifies interactions as major, moderate, or minor, following conventions used by clinical pharmacology references such as Lexicomp and Micromedex. Major interactions can cause life-threatening outcomes or require contraindication. Moderate interactions may require dose adjustment, increased monitoring, or therapeutic substitution. Minor interactions have limited clinical significance but are reported for completeness. Severity ratings are drawn from FDA Prescribing Information, published case reports, and pharmacokinetic studies.

How are cytochrome P450 interactions identified?

CYP450 enzyme interactions are identified by cross-referencing each drug's known substrate, inducer, and inhibitor status for major isoforms including CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5. When a strong inhibitor is combined with a sensitive substrate of the same isoform, the checker flags the pair and provides mechanistic details. For example, fluconazole (CYP2C9 inhibitor) combined with warfarin (CYP2C9 substrate) produces an anticoagulant potentiation interaction that requires INR monitoring.

Does the tool detect pharmacodynamic interactions?

Yes. Pharmacodynamic interactions occur when two drugs act on the same physiological target or pathway, producing additive, synergistic, or antagonistic effects. The checker flags combinations such as two QT-prolonging agents, two CNS depressants, or drugs that both lower blood pressure. These interactions do not involve drug metabolism but can carry significant clinical risk. The checker references QT-Drugs.org, CredibleMeds, and published cardiac safety data for QT interaction identification.

Are herbal supplements and vitamins included in the database?

The checker includes clinically documented herbal and supplement interactions supported by peer-reviewed evidence. Notable examples include St. John's Wort (CYP3A4 and P-glycoprotein inducer), grapefruit juice (CYP3A4 inhibitor), and fish oil (potential additive antiplatelet effect with anticoagulants). Coverage is limited to supplements with established pharmacokinetic or pharmacodynamic interaction data; anecdotal interactions are excluded to minimize false positives.

Should this tool replace consultation with a pharmacist?

No. This checker is an informational screening tool intended to support, not replace, professional pharmaceutical review. A licensed pharmacist or physician considers individual patient factors including renal and hepatic function, age, body weight, genetic polymorphisms (such as CYP2D6 poor metabolizer status), and the full clinical context when evaluating drug interactions. Always review identified interactions with your healthcare team before making any changes to your medication regimen.